Manuel Battegay

Manuel Battegay's AcademicInfluence.com Rankings

Manuel Battegay

Philosophy

#6163

World Rank

#9156

Historical Rank

Logic

#3352

World Rank

#4498

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Manuel Battegay's Degrees

Doctorate Medicine University of Zurich
PhD Infectious Diseases University of Basel

Why Is Manuel Battegay Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Manuel Battegay's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies (2008) (1310)
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. (2010) (1216)
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study (2000) (982)
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study (1997) (655)
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. (2011) (586)
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. (1999) (524)
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study (2019) (512)
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. (1991) (491)
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation. (2020) (439)
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. (2003) (410)
Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice (1994) (366)
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study (2013) (351)
Immune reconstitution in HIV-infected patients. (2004) (337)
Fibroblasts as efficient antigen-presenting cells in lymphoid organs. (1995) (329)
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. (2005) (326)
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. (1999) (298)
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. (1999) (282)
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance (2001) (257)
Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. (2002) (250)
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV * (2008) (242)
Immunological recovery and antiretroviral therapy in HIV-1 infection. (2006) (240)
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules (1995) (240)
Response to combination antiretroviral therapy: variation by age (2008) (230)
Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. (2008) (226)
Correlates of Self-Reported Nonadherence to Antiretroviral Therapy in HIV-Infected Patients: The Swiss HIV Cohort Study (2006) (203)
2019-novel Coronavirus (2019-nCoV): estimating the case fatality rate - a word of caution. (2020) (196)
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. (2011) (190)
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study. (1999) (190)
Prevalence of comedications and effect of potential drug–drug interactions in the Swiss HIV Cohort Study (2010) (189)
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection. (2003) (177)
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. (2010) (175)
Prevalence of risk factors for cardiovascular disease in HIV‐infected patients over time: the Swiss HIV Cohort Study (2006) (166)
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population (2016) (161)
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. (2010) (157)
Ageing with HIV: medication use and risk for potential drug-drug interactions. (2011) (157)
Polyfunctional HCV‐specific T‐cell responses are associated with effective control of HCV replication (2008) (151)
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection. (2002) (150)
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy (2008) (148)
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy. (2002) (145)
Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. (1993) (141)
Outcomes of early switching from intravenous to oral antibiotics on medical wards (2009) (140)
Exclusive Staphylococcus aureus throat carriage: at-risk populations. (2009) (140)
Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection (2011) (139)
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study (2008) (137)
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. (2007) (136)
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. (2009) (134)
Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load (2010) (133)
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0 (2018) (131)
Lipid Profiles for Antiretroviral-Naive Patients Starting Pi- and Nnrti-Based Therapy in the Swiss HIV Cohort Study (2005) (130)
Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. (2005) (128)
High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner--two challenging issues. (2003) (124)
Determinants of HIV-1 broadly neutralizing antibody induction (2016) (124)
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population (2003) (123)
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. (2005) (121)
Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo (2012) (118)
Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008. (2010) (116)
Evidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus Infection (2006) (114)
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection. (2010) (113)
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. (2008) (113)
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV‐positive persons (2016) (113)
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing (2014) (112)
Longitudinal Analysis of Patterns and Predictors of Changes in Self-Reported Adherence to Antiretroviral Therapy: Swiss HIV Cohort Study (2009) (111)
Sexual transmission during the incubation period of primary HIV infection. (2001) (110)
High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coliin Swiss Travellers to South Asia– a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors (2014) (109)
Highly active antiretroviral therapy during early HIV infection reverses T‐cell activation and maturation abnormalities (1998) (107)
Staphylococcus aureus Infections in Injection Drug Users: Risk Factors and Prevention Strategies (2004) (106)
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir (2012) (102)
Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray (2020) (101)
Shortcomings of chest radiography in detecting Pneumocystis carinii pneumonia. (1994) (100)
Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study. (1999) (100)
Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon (1994) (97)
All cause mortality in the Swiss HIV cohort study from 1990 to 2001 in comparison with the Swiss population (2004) (97)
Hodgkin lymphoma in the Swiss HIV Cohort Study. (2009) (96)
Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. (1995) (96)
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival (2003) (95)
HIV Patients Developing Primary CNS Lymphoma Lack EBV-Specific CD4+ T Cell Function Irrespective of Absolute CD4+ T Cell Counts (2007) (94)
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza (2014) (91)
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 (2020) (90)
Adverse events of raltegravir and dolutegravir (2017) (90)
Effect of Early Antiretroviral Therapy during Primary HIV-1 Infection on Cell-Associated HIV-1 Dna and Plasma HIV-1 Rna (2011) (90)
The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV (2015) (88)
Hepatitis C virus transmission among human immunodeficiency virus‐infected men who have sex with men: Modeling the effect of behavioral and treatment interventions (2016) (87)
Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study (2002) (86)
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART (2019) (83)
JC Virus-Specific Immune Responses in Human Immunodeficiency Virus Type 1 Patients with Progressive Multifocal Leukoencephalopathy (2009) (82)
Self-Reported Non-Adherence to Antiretroviral Therapy Repeatedly assessed by Two Questions Predicts Treatment Failure in Virologically Suppressed Patients (2008) (81)
Hepatitis delta-associated mortality in HIV/HBV-coinfected patients. (2017) (80)
A Smoking Cessation Programme in HIV-Infected Individuals: A Pilot Study (2005) (79)
Standard Genotyping Overestimates Transmission of Mycobacterium tuberculosis among Immigrants in a Low-Incidence Country (2016) (79)
HIV Infection Disrupts the Sympatric Host–Pathogen Relationship in Human Tuberculosis (2013) (79)
Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study. (2000) (78)
Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern (2016) (78)
Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. (2014) (77)
Infrequent Transmission of HIV-1 Drug-Resistant Variants (2003) (77)
Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study (2007) (77)
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection (2012) (77)
Interferon-alpha activates signal transducers and activators of transcription 5 and 6 in Daudi cells. (1998) (74)
The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. (2011) (74)
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000–2006 (2008) (72)
Resurgence of HIV Infection among Men Who Have Sex with Men in Switzerland: Mathematical Modelling Study (2012) (72)
Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality (2015) (71)
Does pregnancy influence the course of HIV infection? Evidence from two large Swiss cohort studies. (1998) (71)
Antiretroviral therapy of late presenters with advanced HIV disease. (2008) (71)
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection (2011) (69)
Estimating the Net Contribution of Interleukin-28B Variation to Spontaneous Hepatitis C Virus Clearance (2011) (68)
How to discriminate contamination from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients. (2012) (67)
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray (2021) (67)
Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. (2013) (67)
A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia. (2001) (67)
Surgical and Antimicrobial Treatment of Prosthetic Vascular Graft Infections at Different Surgical Sites: A Retrospective Study of Treatment Outcomes (2014) (67)
Reproductive number of the COVID-19 epidemic in Switzerland with a focus on the Cantons of Basel-Stadt and Basel-Landschaft. (2020) (67)
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012. (2015) (66)
High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. (1997) (66)
Antiviral immune responses of mice lacking MHC class II or its associated invariant chain. (1996) (65)
Secular Trend and Risk Factors for Antimicrobial Resistance in Escherichia coli Isolates in Switzerland 1997–2007 (2009) (65)
Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. (2007) (64)
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study (2008) (63)
Highly Active Antiretroviral Therapy (2012) (62)
Late Presentation of HIV-Infected Individuals (2007) (62)
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study (2004) (61)
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality (2015) (60)
Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region (1996) (60)
Symptom Management in HIV/AIDS: Advancing the Conceptualization (2005) (60)
TB in a low-incidence country: differences between new immigrants, foreign-born residents and native residents. (2007) (59)
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study (2014) (58)
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point. (2004) (58)
Risk of Cardiovascular Events and Blood Pressure Control in Hypertensive HIV-Infected Patients: Swiss HIV Cohort Study (SHCS) (2013) (57)
Scabies Outbreak in an Intensive Care Unit with 1,659 Exposed Individuals—Key Factors for Controlling the Outbreak (2009) (57)
Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis. (2015) (57)
Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption (2011) (56)
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. (2009) (55)
Acute renal failure on immune reconstitution in an HIV-positive patient with miliary tuberculosis. (2004) (55)
Importance of Mental Health Assessment in HIV‐Infected Outpatients (2001) (55)
Association of Alcohol Consumption and HIV Surrogate Markers in Participants of the Swiss HIV Cohort Study (2013) (54)
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. (2016) (53)
HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study. (2016) (53)
Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients (2003) (53)
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. (2008) (53)
RASH WITH AMOXYCILLIN-CLAVULANATE THERAPY IN HIV-INFECTED PATIENTS (1989) (53)
HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study. (2016) (53)
Gastroenteritis outbreak with norovirus in a Swiss university hospital with a newly identified virus strain. (2003) (53)
Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing. (2016) (53)
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. (2016) (53)
[Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates] (1993) (52)
General and specific immunosuppression caused by antiviral T‐cell responses (1999) (52)
Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention-results from a prospective observational cohort study. (2016) (52)
Reasons for late presentation to HIV care in Switzerland (2015) (51)
Mycobacterium tuberculosis Transmission in a Country with Low Tuberculosis Incidence: Role of Immigration and HIV Infection (2011) (51)
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. (2008) (51)
Effect of Highly Active Antiretroviral Therapy on Hospitalization Characteristics of HIV-Infected Patients (2002) (50)
CD 4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years The Swiss HIV Cohort Study (2003) (50)
Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation (2012) (50)
Contribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals: A Longitudinal Study (2009) (49)
Cutaneous Plasmablastic Lymphoma in an HIV-Positive Male: An Unrecognized Cutaneous Manifestation (2004) (49)
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy (2010) (49)
Vertebral osteomyelitis caused by Actinobaculum schaalii: a difficult-to-diagnose and potentially invasive uropathogen (2007) (49)
Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis? (2014) (48)
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations (2020) (48)
Disentangling Human Tolerance and Resistance Against HIV (2014) (47)
Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses (2020) (47)
Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections. (2015) (46)
Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population (2015) (46)
Reasons for discontinuation of first highly active antiretroviral therapy in a cohort of proteinase inhibitor-naive HIV-infected patients. (2001) (46)
Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons (2008) (46)
Incidence and risk factors for hypertension among HIV patients in rural Tanzania – A prospective cohort study (2017) (46)
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses (2018) (46)
Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of antiretroviral triple combination therapy. Swiss HIV Cohort Study. (1999) (45)
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients (2007) (45)
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients (2007) (45)
Outcome of smoking cessation counselling of HIV‐positive persons by HIV care physicians (2012) (45)
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA* (2013) (45)
Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study. (2016) (45)
Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania (2013) (45)
Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis (2008) (44)
Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus. (2009) (44)
Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors? (2014) (44)
Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy (2007) (44)
Introduction to Machine Learning in Digital Healthcare Epidemiology (2018) (44)
Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells (1993) (43)
Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs (2016) (43)
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia (2021) (43)
Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis (1994) (43)
Is unsafe sexual behaviour increasing among HIV-infected individuals? (2004) (42)
A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2 (1997) (42)
Eligibility for and Outcome of Hepatitis C Treatment of HIV-Coinfected Individuals in Clinical Practice: The Swiss HIV Cohort Study (2006) (41)
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients (2000) (41)
Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes. (2012) (41)
CD4+ T-Cell Count Increase in HIV-1-Infected Patients with Suppressed Viral Load Within 1 year after start of antiretroviral therapy (2007) (40)
Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study. (1998) (40)
Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes (2018) (39)
Treatment and Prognosis of AIDS-Related Lymphoma in the Era of Highly Active Antiretroviral Therapy: Findings from the Swiss HIV Cohort Study (2007) (39)
Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV. (2014) (39)
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals (2017) (39)
Cost-Effectiveness of Genotypic Antiretroviral Resistance Testing in HIV-Infected Patients with Treatment Failure (2007) (39)
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. (2012) (39)
Antimicrobial prophylaxis to prevent surgical site infections in a rural sub-Saharan hospital. (2006) (38)
Downregulation of Bcl-2, but not of Bax or Bcl-x, is associated with T lymphocyte apoptosis in HIV infection and restored by antiretroviral therapy or by interleukin 2. (1999) (38)
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection. (2013) (38)
Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death (2011) (38)
[Epidemiology of HIV]. (2014) (37)
Persistent Apoptosis in HIV-1-Infected Individuals Receiving Potent Antiretroviral Therapy Is Associated With Poor Recovery of CD4 T Lymphocytes (2004) (37)
Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature (2020) (37)
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir (2005) (36)
Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study (2015) (36)
Intranasal influenza vaccine in a working population. (2004) (36)
Co-Trimoxazole Prophylaxis Is Associated with Reduced Risk of Incident Tuberculosis in Participants in the Swiss HIV Cohort Study (2014) (35)
Burden of serious fungal infections in Tanzania (2015) (35)
Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study. (2016) (35)
Gastrointestinal bleeding associated with rivaroxaban administration in a treated patient infected with human immunodeficiency virus. (2014) (35)
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity (2017) (35)
HIV-1-infected patients with focal neurologic signs: diagnostic role of PCR for Toxoplasma gondii, Epstein-Barr virus, and JC virus. (1998) (35)
Body Fat Changes among Antiretroviral-Naive Patients on Pi- and Nnrti-Based Haart in the Swiss HIV Cohort Study (2005) (35)
Prevention of mother-to-child transmission of HIV Option B+ cascade in rural Tanzania: The One Stop Clinic model (2017) (34)
Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition (2011) (34)
CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland. (2009) (34)
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect (2020) (34)
Prospective study of a panfungal PCR assay followed by sequencing, for the detection of fungal DNA in normally sterile specimens in a clinical setting: a complementary tool in the diagnosis of invasive fungal disease? (2013) (33)
Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study (2015) (33)
Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection (2011) (33)
Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis. (2016) (33)
Infections requiring hospitalization of injection drug users who participated in an injection opiate maintenance program. (2002) (33)
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study (2017) (33)
Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation (2010) (32)
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study. (1999) (32)
Inflammatory Bowel Perforation During Immune Restoration After One Year of Antiretroviral and Antituberculous Therapy in an HIV-1–Infected Patient (2002) (32)
A rifampicin-containing antibiotic treatment improves outcome of staphylococcal deep sternal wound infections. (2010) (32)
HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy. (2008) (31)
Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10. (2011) (31)
Extended Spectrum β-Lactamase–producing Escherichia coli in Neonatal Care Unit (2010) (31)
High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Men Who Have Sex With Men (2018) (31)
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case–control study (2004) (31)
Morbidity and mortality in HIV-infected individuals - a shift towards comorbidities. (2009) (30)
Cohort profile: The Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) - A prospective HIV cohort in rural Tanzania. (2017) (30)
No Risk of Surgical Site Infections From Residual Bacteria After Disinfection With Povidone-Iodine-Alcohol in 1014 Cases: A Prospective Observational Study (2012) (30)
HIV-1 p24 May Persist During Long-Term Highly Active Antiretroviral Therapy, Increases Little During Short Treatment Breaks, and Its Rebound After Treatment Stop Correlates With CD4+ T Cell Loss (2005) (29)
Impact of a national HIV voluntary counselling and testing (VCT) campaign on VCT in a rural hospital in Tanzania (2010) (29)
Increasing prevalence of infectious diseases in asylum seekers at a tertiary care hospital in Switzerland (2017) (29)
Productivity costs and determinants of productivity in HIV-infected patients. (2004) (29)
Enterococci, Clostridium difficile and ESBL-producing bacteria: epidemiology, clinical impact and prevention in ICU patients. (2014) (28)
Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV (2019) (28)
Small Dense Lipoproteins, Apolipoprotein B, and Risk of Coronary Events in HIV-Infected Patients on Antiretroviral Therapy: The Swiss HIV Cohort Study (2012) (28)
Carriage of Staphylococcus aureus Among Injection Drug Users: Lower Prevalence in an Injection Heroin Maintenance Program Than in an Oral Methadone Program (2004) (28)
A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa (2015) (28)
A Comparison of Initial Antiretroviral Therapy in the Swiss HIV Cohort Study and the Recommendations of the International AIDS Society-USA (2011) (28)
Vaccine adjuvants--understanding molecular mechanisms to improve vaccines. (2014) (27)
Uptake of guidelines on prevention of mother-to-child transmission of HIV in rural Tanzania: time for change. (2013) (27)
High Rates of Subsequent Asymptomatic Sexually Transmitted Infections and Risky Sexual Behavior in Patients Initially Presenting With Primary Human Immunodeficiency Virus-1 Infection (2018) (27)
CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART (2016) (26)
SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event (2021) (26)
Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort Study. (1999) (26)
A decade of HIV care in rural Tanzania: Trends in clinical outcomes and impact of clinic optimisation in an open, prospective cohort (2017) (26)
Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy (2012) (26)
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study (2015) (26)
Starting or Changing Therapy – A Prospective Study Exploring Antiretroviral Decision–Making (2005) (25)
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS). (2021) (25)
Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas? (2007) (25)
Direct Costs of a Contact Isolation Day: A Prospective Cost Analysis at a Swiss University Hospital (2017) (25)
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity (2018) (25)
The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients (2013) (25)
Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly (2019) (24)
Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology (1992) (24)
A highly virulent variant of HIV-1 circulating in the Netherlands (2022) (23)
Emergence of Glutaraldehyde-Resistant Pseudomonas aeruginosa (2011) (23)
Lipodystrophy Syndrome by HAART in HIV-Infected Patients: Manifestation, Mechanisms and Management (2002) (23)
Erythema of the proximal nailfold in HIV-infected patients. (1996) (23)
Onset and pattern of substance use in intravenous drug users of an opiate maintenance program. (2001) (23)
The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals. (2015) (22)
Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST (2007) (22)
Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on Cytochromes (2017) (22)
Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-Term Mortality in Staphylococcus aureus Bloodstream Infection: A Propensity Score–Matched Cohort Study (2016) (22)
Safety and Efficacy of Once-Daily Nevirapine Dosing: A Multicohort Study (2009) (22)
Automated high throughput analysis of antiretroviral drugs in dried blood spots. (2017) (22)
Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-Κb Activation (2012) (21)
Does Pregnancy Influence the Course of HIV Infection? Evidence from Two Large Swiss Cohort Studies (1998) (21)
Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C (1995) (21)
Combination therapy for multidrug‐resistant cytomegalovirus disease (2015) (21)
Impact of Previous Virological Treatment Failures and Adherence on the Outcome of Antiretroviral Therapy in 2007 (2009) (21)
The brain entry of HIV-1 protease inhibitors is facilitated when used in combination. (2013) (21)
Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort (2016) (21)
Frequent Door Openings During Cardiac Surgery are Associated with Increased Risk for Surgical Site Infection: A Prospective Observational Study. (2018) (21)
Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study (2018) (20)
Brief Report: No HIV Transmission From Virally Suppressed Mothers During Breastfeeding in Rural Tanzania (2018) (20)
Evaluation of treatment outcomes for Stenotrophomonas maltophilia bacteraemia (2014) (19)
Genotypic and phenotypic resistance testing of HIV-1 in routine clinical care (2005) (19)
Low rates of influenza vaccination uptake among healthcare workers: Distinguishing barriers between occupational groups. (2020) (18)
Eosinophilia in patients infected with the human immunodeficiency virus (1997) (18)
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons (2015) (18)
Rare AIDS-Defining Diseases in the Swiss HIV Cohort Study (1999) (18)
Is There a Relation between Risk Groups or Initial CD4 T Cell Counts and Prevalence of Seborrheic Dermatitis in HIV-Infected Patients? (1999) (18)
Epidemiology of SARS-CoV-2 Emergence Amidst Community-Acquired Respiratory Viruses. (2020) (18)
Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared. (2016) (18)
Efavirenz in an Obese HIV-Infected Patient – a Report and An In Vitro–In Vivo Extrapolation Model Indicate Risk of Underdosing (2012) (18)
Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study * (2011) (18)
Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins (1993) (18)
Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study (2017) (17)
Lung resection in hematologic patients with pulmonary invasive fungal disease. (2012) (17)
Immunity to hepatitis C virus: A further piece of the puzzle (1996) (17)
Reference curves for CD4 T‐cell count response to combination antiretroviral therapy in HIV‐1‐infected treatment‐naïve patients (2017) (17)
Genotype distribution of hepatitis C virus infection in Greece: correlation with different risk factors and response to interferon therapy. (1998) (17)
A pain in the neck: probiotics for ulcerative colitis. (2009) (17)
Characterising the epidemic spread of influenza A/H3N2 within a city through phylogenetics (2020) (17)
Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)–Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination Schedule (2018) (17)
Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study (2016) (17)
Less than 28 days of intravenous antibiotic treatment is sufficient for suppurative thrombophlebitis in injection drug users. (2008) (17)
Hepatitis associated with hepatitis A superinfection in patients with chronic hepatitis C. (1998) (16)
High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men (2019) (16)
Changing Trends in International Versus Domestic HCV Transmission in HIV-Positive Men Who Have Sex With Men: A Perspective for the Direct-Acting Antiviral Scale-Up Era (2019) (16)
Evidence for prevention and screening: recommendations in adults. (2002) (16)
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy. (2009) (16)
Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia-a 7-year individual and population-based analysis. (2017) (16)
Viral Suppression Rates in Salvage Treatment With Raltegravir Improved With the Administration of Genotypic Partially Active or Inactive Nucleoside/Tide Reverse Transcriptase Inhibitors (2011) (16)
The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events (2016) (16)
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland (2016) (15)
Efficacy, tolerability and risk factors for virological failure of darunavir‐based therapy for treatment‐experienced HIV‐infected patients: the Swiss HIV Cohort Study (2011) (15)
Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression (2017) (15)
Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since Infection. (2019) (15)
Higher risk of incident hepatitis C virus coinfection among men who have sex with men, in whom the HIV genetic bottleneck at transmission was wide. (2014) (15)
Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since Infection. (2019) (15)
Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study. (2021) (15)
Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning (2021) (15)
Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications (2018) (15)
Prevalence and management of drug–drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study† (2019) (15)
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis (2017) (15)
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis (2017) (15)
Clinical spectrum of the immune restoration inflammatory syndrome (2006) (15)
Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections (2021) (15)
Access to antiretroviral therapy. (2000) (15)
Non‐tolerant B cells cause autoimmunity in anti‐CD8 IgG2a‐transgenic mice (1996) (15)
Intravenous opiate maintenance in a cohort of injecting drug addicts. (2003) (15)
Effect of Antiretroviral Therapy on Apoptosis Markers and Morphology in Peripheral Lymph Nodes of HIV-Infected Individuals (2008) (15)
Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life setting. (2019) (14)
Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infection. (2001) (14)
Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR) (2021) (14)
Epstein–Barr Virus Load Correlating with Clinical Manifestation and Treatment Response in a Patient with Angioimmunoblastic T-Cell Lymphoma (2003) (14)
Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures (2020) (14)
Implementation and Operational Research: An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa (2016) (14)
Moving up from 3 by 5. (2006) (14)
Prospective assessment of loss to follow‐up: incidence and associated factors in a cohort of HIV‐positive adults in rural Tanzania (2020) (14)
A Longitudinal Analysis of Healthcare Costs after Treatment Optimization following Genotypic Antiretroviral Resistance Testing: Does Resistance Testing pay off? (2005) (14)
Long-Term Virological Response to Multiple Sequential Regimens of Highly Active Antiretroviral Therapy for HIV Infection (2004) (14)
Successful treatment of hepatitis B-associated polyarteritis nodosa with a combination of lamivudine and conventional immunosuppressive therapy: a case report. (2000) (14)
2 0 1 7 CD 4 / CD 8 ratio and CD 8 counts predict CD 4 response in HIV-1-infected drug naive and in patients on cART (2016) (14)
HIV resistance testing and detected drug resistance in Europe (2015) (13)
Anxiety in health care workers after exposure to potentially HIV-contaminated blood or body fluids. (2002) (13)
Prior Therapy Influences the Efficacy of Lamivudine Monotherapy in Patients with Lamivudine-resistant HIV-1 Infection (2009) (13)
Low postseroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors. (2010) (13)
Repeated Syphilis Episodes in HIV-Infected Men Who Have Sex With Men: A Multicenter Prospective Cohort Study on Risk Factors and the Potential Role of Syphilis Immunity (2020) (13)
Repeated Syphilis Episodes in HIV-Infected Men Who Have Sex With Men: A Multicenter Prospective Cohort Study on Risk Factors and the Potential Role of Syphilis Immunity (2020) (13)
Simultaneous occurrence of 2 HIV-related immunereconstitution diseases after initiation of highly active antiretroviral therapy. (2001) (13)
Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho (2020) (13)
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA (2012) (13)
Global Genomic Analysis of SARS-CoV-2 RNA Dependent RNA Polymerase Evolution and Antiviral Drug Resistance (2021) (13)
Predicting smoking cessation and its relapse in HIV‐infected patients: the Swiss HIV Cohort Study (2015) (13)
Home-based oral self-testing for absent and declining individuals during a door-to-door HIV testing campaign in rural Lesotho (HOSENG): a cluster-randomised trial. (2020) (13)
Red fingers syndrome in HIV patients (1996) (13)
Reduced infections with HIV and hepatitis A during a Swiss intravenous opiate maintenance program. (1999) (13)
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study (2011) (13)
Implementation and Operational Research (2016) (12)
Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study (2005) (12)
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study (2007) (12)
Rectal swab for detection of norovirus by real-time PCR: similar sensitivity compared to faecal specimens. (2014) (12)
Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand (2018) (12)
Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV (2022) (12)
Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy (2010) (12)
Previous exposure in a high-risk area for travellers' diarrhoea within the past year is associated with a significant protective effect for travellers' diarrhoea: a prospective observational cohort study in travellers to South Asia. (2017) (12)
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging patients enrolled in the Swiss HIV Cohort Study. (2019) (12)
The decision to get vaccinated against influenza. (2004) (12)
Value of the Pitt Bacteraemia Score to predict short-term mortality in Staphylococcus aureus bloodstream infection: a validation study. (2017) (12)
Sonography to Rule Out Tuberculosis in Sub-Saharan Africa: A Prospective Observational Study (2019) (12)
Detection of drug‐resistant HIV minorities in clinical specimens and therapy failure (2008) (12)
Using dried blood spots to facilitate therapeutic drug monitoring of antiretroviral drugs in resource-poor regions (2018) (12)
Once-daily directly observed therapy lopinavir/ritonavir plus indinavir as a protease inhibitor-only salvage therapy in heavily pretreated HIV-1-infected patients: a pilot study (2006) (11)
Bioavailability of extended-release nevirapine 400 and 300 mg in HIV-1: a multicenter, open-label study. (2011) (11)
[Epidemiology of skin diseases in HIV-infected patients: a prospective cohort study]. (1996) (11)
Gynecomastia and potent antiretroviral therapy. (2004) (11)
Sexual risk behavior in HIV-infected injection drug users. (2004) (11)
Hearing Loss after Discontinuing Secondary Prophylaxis for Cryptococcal Meningitis: Relapse or Immune Reconstitution? (2006) (11)
Determinants of SARS-CoV-2 transmission to guide vaccination strategy in a city (2020) (11)
Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults (2015) (11)
Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay (2020) (11)
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment (2020) (11)
Mechanisms of Drug Interactions II: Transport Proteins (2011) (11)
Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: In vitro and in vivo correlation (2015) (11)
Low Levels of Mannan-Binding Lectin or Ficolins Are Not Associated with an Increased Risk of Cytomegalovirus Disease in HIV-Infected Patients (2012) (11)
How reliable is an undetectable viral load? (2009) (11)
Optimising the performance of an outpatient setting. (2004) (11)
Health care provider communication training in rural Tanzania empowers HIV‐infected patients on antiretroviral therapy to discuss adherence problems (2017) (11)
Extrapulmonary tuberculosis in HIV-infected patients in rural Tanzania: The prospective Kilombero and Ulanga antiretroviral cohort (2020) (10)
Effect of ageing on antiretroviral drug pharmacokinetics using clinical data combined with modelling and simulation (2020) (10)
Candida krusei– a serious complication in patients with hematological malignancies: successful treatment with caspofungin (2008) (10)
Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma (2017) (10)
Short‐course amphotericin B in addition to sertraline and fluconazole for treatment of HIV‐associated cryptococcal meningitis in rural Tanzania (2019) (10)
The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir (2014) (10)
When time is more than money: the allocation of time between work and leisure in HIV-infected patients. (2007) (10)
Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease (2014) (10)
Epidemiology of SARS-CoV-2 Emergence Amidst Community-Acquired Respiratory Viruses (2020) (10)
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy (2007) (10)
Hepatitis C virus transmission among HIV-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions (2016) (10)
Ecological Study of the Predictors of Successful Management of Dyslipidemia in HIV-Infected Patients on ART: the Swiss HIV Cohort Study (2007) (10)
Salvage treatment against human immunodeficiency virus. (1999) (10)
Age-related comorbidities and mortality in people living with HIV in rural Tanzania. (2019) (10)
Virosomal influenza-vaccine induced immunity in HIV-infected individuals with high versus low CD4+ T-cell counts: clues towards a rational vaccination strategy (2010) (10)
Protease inhibitor-sparing simplified maintenance therapy: a need for perspective. (2004) (10)
HIV-positive child with epidermodysplasia verruciformis-like lesions and homozygous mutation in TMC6. (2010) (9)
Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients. (2019) (9)
COVID-19 Triage and Test Center: Safety, Feasibility, and Outcomes of Low-Threshold Testing (2020) (9)
Tuberculous spondylitis diagnosed through Xpert MTB/RIF assay in urine: a case report (2016) (9)
VIBRA trial – Effect of village-based refill of ART following home-based same-day ART initiation vs clinic-based ART refill on viral suppression among individuals living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho (2019) (9)
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV (2009) (9)
Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and -2. (2017) (9)
Eradication of an epidemic methicillin-resistant Staphylococcus aureus (MRSA) from a geriatric university hospital: evidence from a 10-year follow-up (2010) (9)
Early participation in an HIV cohort study slows disease progression and improves survival (1998) (9)
Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy (2016) (9)
cART prescription trends in a prospective HIV cohort in rural Tanzania from 2007 to 2011 (2012) (9)
Entwicklung und Etablierung einer erweiterten und vertieften HIV/Aids- Pflegepraxis (2002) (9)
Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study (2017) (9)
European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome Statements (2016) (9)
T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells. (2015) (9)
Exploring the doctor-patient relationship reduces staff stress and enhances empathy when caring for AIDS patients. (1991) (9)
Prevalence and Evolution of Renal Impairment in People Living With HIV in Rural Tanzania (2018) (9)
A Diagnostic HIV-1 Tropism System Based on Sequence Relatedness (2014) (9)
Prevalence and Evolution of Renal Impairment in People Living With HIV in Rural Tanzania (2018) (9)
Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity. (2020) (8)
Comparing Immunoassays for SARS-CoV-2 Antibody Detection in Patients with and without Laboratory-Confirmed SARS-CoV-2 Infection (2021) (8)
Correlating HIV tropism with immunological response under combination antiretroviral therapy (2016) (8)
European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16‐17 November 2016: a summary (2018) (8)
Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity. (2020) (8)
High Mortality of Non-Fournier Necrotizing Fasciitis With Enterobacteriales: Time to Rethink Classification? (2018) (8)
Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with Switzerland (2018) (8)
Acute kidney injury KDIGO stage 2 to 3 in HIV-positive patients treated with cART--a case series over 11 years in a cohort of 1,153 patients. (2015) (8)
Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection (2015) (8)
Prevalence of potential drug-drug interactions in patients of the Swiss HIV Cohort Study in the era of HIV integrase inhibitors. (2020) (8)
Is admission screening for Pseudomonas aeruginosa useful in haematologic patients? A prospective study with 1310 patients. (2015) (8)
A short tool to screen HIV-infected patients for mild neurocognitive disorders – a pilot study (2014) (8)
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? (2018) (8)
Review article: HCV ? STAT-C era of therapy (2010) (8)
Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens (2017) (7)
Effect of Antiretroviral Therapy on Viral Load, CD4 Cell Count, and Progression to Acquired Immunodeficiency Syndrome in a Community Human Immunodeficiency VirusInfected Cohort (2000) (7)
A Case Series of Acquired Drug Resistance-Associated Mutations in Human Immunodeficiency Virus-Infected Children: An Emerging Public Health Concern in Rural Africa (2015) (7)
Cotrimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study (2014) (7)
Virologic and Immunologic Responses in Treatment-Naive Patients to Ritonavir-Boosted Atazanavir or Efavirenz With a Common Backbone (2014) (7)
Oral manifestation of disseminated Mycobacterium kansasii infection in a patient with AIDS. (1996) (7)
Schistosomiasis: from established diagnostic assays to emerging micro/nanotechnology-based rapid field testing for clinical management and epidemiology (2019) (7)
Mycobacterium intracellulare infection in non-HIV infected patient in a region with a high burden of tuberculosis (2012) (7)
Physiologically Based Pharmacokinetic Modelling to Investigate the Impact of the Cytokine Storm on CYP3A Drug Pharmacokinetics in COVID‐19 Patients (2021) (7)
Antiretroviral monotherapy: should we abandon the principles of successful antiretroviral therapy? (2010) (7)
High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania – A prospective cohort study (2020) (7)
SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to mass gathering events (2020) (7)
Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection. (2004) (7)
Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study (2021) (7)
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study (2017) (7)
Darunavir concentrations in CSF of HIV‐infected individuals when boosted with cobicistat versus ritonavir (2017) (7)
Dolutegravir plasma levels after gastric bypass surgery. (2017) (7)
The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis (2018) (7)
A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 With Coinfections, Noncommunicable Diseases, and Opportunistic Diseases. (2019) (6)
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study. (2015) (6)
Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries (2002) (6)
Real-life management of drug-drug interactions between antiretrovirals and statins. (2020) (6)
The use of lipid-lowering agents in HIV-infected patients. (2001) (6)
[HIV infection and syphilis. Case description and literature review]. (1991) (6)
Response to a sexual risk reduction intervention provided in combination with hepatitis C treatment by HIV/HCV co-infected men who have sex with men: a reflexive thematic analysis (2021) (6)
Round-table multidisciplinary counselling of couples with HIV prior to assisted reproduction. (2008) (6)
Screening HIV-positive men who have sex with men for hepatitis C re-infection risk: is a single question on condom-use enough? A sensitivity analysis (2019) (6)
The HOSENG trial – Effect of the provision of oral self-testing for absent and refusing individuals during a door-to-door HIV-testing campaign on testing coverage: protocol of a cluster-randomized clinical trial in rural Lesotho (2019) (6)
Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study. (2021) (6)
Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis (2010) (6)
[Focal mycobacterial lymphadenitis after starting highly active antiretroviral therapy]. (1999) (6)
Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug‐Drug Interaction Magnitudes in the Elderly (2020) (6)
Ueber den Ersatz von negativen Gruppen durch Hydroxylgruppen in orthosubstituirten Diazoniumsalzen (6)
Real-life management of drug-drug interactions between antiretrovirals and statins. (2020) (6)
Cost Estimates for Human Immunodeficiency Virus (HIV) Care and Patient Characteristics for Health Resource Use From Linkage of Claims Data With the Swiss HIV Cohort Study (2018) (6)
Chest pain after travel to the tropics (2004) (6)
Disappearance of an Intracerebral Arteriovenous Malformation in an HIV-Infected Patient after Initiation of HAART (2002) (6)
Physiologically‐Based Pharmacokinetic Modeling to Support the Clinical Management of Drug–Drug Interactions With Bictegravir (2021) (6)
Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study (2020) (6)
Secondary erythermalgia in an HIV-infected patient. Is there a pathogenic relationship? (1996) (6)
Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model‐based analysis in Switzerland (2018) (6)
Epidemiology and precision of SARS‐CoV‐2 detection following lockdown and relaxation measures (2020) (6)
No Effect of Pegylated Interferon-&agr; on Total HIV-1 DNA Load in HIV-1/HCV Coinfected Patients (2018) (6)
Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of HIV Transmission in MSM. (2020) (6)
The influence of human genetic variation on Epstein–Barr virus sequence diversity (2021) (6)
[Of bugs and joints. Oligoarthritis caused by Tropheryma whipplei]. (2011) (6)
Age-related comorbidities and mortality in people living with HIV in rural Tanzania: data from a prospective cohort study. (2019) (6)
A Systematic Phylogenetic Approach to Study the Interaction of HIV-1 With Coinfections, Noncommunicable Diseases, and Opportunistic Diseases. (2019) (6)
Analysis of neutralizing antibody specificities of different strains of lymphocytic choriomeningitis virus with strain-specific immune sera. (1993) (5)
11th European AIDS Conference (EACS) (2008) (5)
Etravirine: a good option for concomitant use with chemotherapy for Hodgkin’s lymphoma (2015) (5)
Identification of influenza urban transmission patterns by geographical, epidemiological and whole genome sequencing data: protocol for an observational study (2019) (5)
CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study (2010) (5)
Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study (2020) (5)
Why do sub‐Saharan Africans present late for HIV care in Switzerland? (2019) (5)
[Psychosocial aspects on the treatment of HIV-infection]. (2014) (5)
Reference curves for CD 4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-na € ı ve patients (2016) (5)
Critical issues of HIV treatment in the era of highly active antiretroviral therapy (2001) (5)
Expansion of interferon‐γ‐secreting HIV‐specific T cells during successful antiretroviral therapy (2013) (5)
Increased Epstein-Barr virus-specific antibody-levels in HIV-infected individuals developing primary central nervous system lymphoma. (2007) (5)
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor‐naive HIV‐infected patients: the Swiss HIV Cohort Study (2002) (5)
Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center study (2020) (5)
Hepatitis delta virus RNA in serum of patients with chronic delta hepatitis (1994) (5)
Long-term outcome after SARS-CoV-2 infection in healthcare workers: a single centre cohort study. (2021) (5)
Klinische Infektiologie (2018) (5)
Stronger correlation between antibiotic use and the incidence of Clostridium difficile determined by culture results instead of faecal toxin detection only (2010) (5)
SARS-CoV-2 Vaccine Alpha and Delta Variant Breakthrough Infections Are Rare and Mild but Can Happen Relatively Early after Vaccination (2021) (5)
Impfungen gegen Pneumokokken und Influenza (2010) (4)
Der Wert der klinischen Infektiologie (2005) (4)
Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores (2020) (4)
Evidenzbasierte Medizin (2008) (4)
The coArtHA trial—identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: study protocol for a randomized controlled trial (2020) (4)
Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study (2021) (4)
Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: The VIBRA cluster-randomized clinical trial (2021) (4)
Early off-label treatment during pandemics? A dilemma. (2020) (4)
Clinical assessment of potential drug interactions of faldaprevir, a hepatitis C virus protease inhibitor, with darunavir/ritonavir, efavirenz, and tenofovir. (2014) (4)
Characterization of pathogen‐inactivated COVID‐19 convalescent plasma and responses in transfused patients (2022) (4)
Research article Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV Cohort Study (2005) (4)
Global surveillance of potential antiviral drug resistance in SARS-CoV-2: proof of concept focussing on the RNA-dependent RNA polymerase (2021) (4)
Symptom manageability in Swiss HIV-infected patients. (2013) (4)
HIV‐associated neurocognitive impairment in stable people living with HIV on ART in rural Tanzania (2020) (4)
Plea for Standardized Reporting and Justification of Propensity Score Methods. (2018) (4)
Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma (2019) (4)
Two versus three-class antiretroviral therapy in antiretroviral-naive patients in different time periods of the HAART era. (2007) (4)
Mortality Rate in a Cohort of People Living With HIV in Rural Tanzania After Accounting for Unseen Deaths Among Those Lost to Follow-up (2020) (4)
SWISS HIV COHORT STUDY. PRODUCTIVITY COSTS AND DETERMINANTS OF PRODUCTIVITY IN HIV-INFECTED PATIENTS (2004) (4)
Failure to return pillbox is a predictor of being lost to follow‐up among people living with HIV on antiretroviral therapy in rural Tanzania (2021) (4)
HIV-Infected Patients Developing Tuberculosis Disease Show Early Changes in the Immune Response to Novel Mycobacterium tuberculosis Antigens (2021) (4)
Longitudinal Progression of Subclinical Coronary Atherosclerosis in Swiss HIV-Positive Compared With HIV-Negative Persons Undergoing Coronary Calcium Score Scan and CT Angiography (2020) (4)
Mansonella perstans-Filariose nach Aufenthalt in Kamerun (2002) (4)
Boosted darunavir, emtricitabine and tenofovir pharmacokinetics in sthe early and late postgastric bypass surgery periods. (2018) (4)
Evaluation of unstructured medical school examinations: prospective observational study. (2003) (4)
Neutralizing antiviral antibodies reduce hematogenic viral spread but not antiviral cytotoxic T cell induction and subsequent immunopathology. (2001) (4)
[Developing and establishing an expanded and more comprehensive HIV/AIDS nursing practice]. (2002) (4)
[Prevention of infections]. (2010) (4)
Does HIV antiretroviral therapy still need its backbone? (2014) (4)
Viral diversity from next-generation sequencing of HIV-1 samples provides precise estimates of infection recency and time since infection (2019) (3)
[Vaccination against pneumococci and influenza. How good is the evidence?]. (2011) (3)
[Primary HIV infection]. (2004) (3)
Moving up from 3 by 5. (2006) (3)
EFFECT OF FALDAPREVIR ON ATAZANAVIR PHARMACOKINETICS IN PATIENTS WITH HIV/HCV CO-INFECTION (2014) (3)
Year : 2008 CD 4 + T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy (2009) (3)
Impact of protease polymorphisms and viral fitness on human immunodeficiency virus (HIV) type 1 viremia in untreated HIV-1 infection. (2002) (3)
Physiologically‐Based Pharmacokinetic Modeling Combined with Swiss HIV Cohort Study Data Supports No Dose Adjustment of Bictegravir in Elderly Individuals Living With HIV (2021) (3)
Thymocyte Selection and Peripheral Tolerance Using the Lymphocytic Choriomeningitis Virus as a Model Antigen (1994) (3)
Population‐based outcome analysis of diffuse large B‐cell lymphoma in people living with HIV infection and competent individuals (2018) (3)
Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study (2018) (3)
Der internistische Check-up (2005) (3)
[HIV-infection, HAART (highly-active antiretroviral therapy) and hyperlipidemia]. (2003) (3)
Incidental Findings on Coronary Computed Tomography Angiography in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Persons (2018) (3)
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial (2020) (3)
Whole body protein turnover in HIV-infected patients (1997) (3)
Digging Out the Evidence-How Strong Is the IDSA Recommendation Against Antibiotic Prophylaxis in Basilar Skull Fracture and Cerebrospinal Fluid Leakage? (2018) (3)
Long‐Term Evaluation of T‐Cell Subset Changes After Effective Combination Antiretroviral Therapy During Asymptomatic HIV‐Infection (2001) (3)
[Postoperative wound infections: essentials for the internal medicine]. (2010) (3)
A qualitative study on safety perception among healthcare workers of a tertiary academic care center during the SARS-CoV-2 pandemic (2022) (3)
Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment. (2020) (3)
Antiretroviral therapy after cryptococcal meningitis. (2014) (3)
Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of Human Immunodeficiency Virus Transmission in Men Who Have Sex With Men (2020) (3)
Are three antiseptic paints needed for safe preparation of the surgical field? A prospective cohort study with 239 patients (2020) (3)
Erratum: Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection (Journal of Virology (2006) 80, 22, (11094-11104)) (2007) (3)
How much money can be saved by applying intravenous antibiotics once instead of several times a day? (2010) (3)
[Smoking cessation for HIV infected patients]. (2003) (3)
HLA‐Bw4 identifies a population of HIV‐infected patients with an increased capacity to control viral replication after structured treatment interruption (2012) (3)
Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of Human Immunodeficiency Virus Transmission in Men Who Have Sex With Men (2020) (3)
Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment (2019) (3)
Mortality in a Cohort of People Living with HIV in Rural Tanzania, Accounting for Unseen Mortality Among Those Lost to Follow-up. (2020) (3)
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland (2022) (3)
Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk prediction (2019) (3)
Bereit für die antiretrovirale Therapie? Die Entscheidungsfindung aus Sicht von HIV-Infizierten (2005) (3)
[Anemia, neutropenia and thrombocytopenia: hematological findings and HIV]. (2001) (2)
Diagnostik bei ambulant erworbener Pneumonie (2007) (2)
Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models (2022) (2)
Skin problems in immunodeficient patients. (2012) (2)
Therapie schwerer Pilzinfektionen (2003) (2)
HIV im südlichen Afrika: wo stehen wir heute? (2019) (2)
Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study. (2021) (2)
[Mucocutaneous infections in immunosuppression]. (2009) (2)
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART (2020) (2)
Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient—a case report and review of the literature (2021) (2)
Relationship between erythema of the proximal nailfold in HIV-infected patients and hepatitis C virus infection (1998) (2)
Influence of hepatitis G virus infection on liver disease (1997) (2)
Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence. (2019) (2)
Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo (2020) (2)
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
Contrary to HIV, hepatitis C virus is not associated with erythrocytes in vivo. (2005) (2)
SPHN/PHRT: Forming a Swiss-Wide Infrastructure for Data-Driven Sepsis Research (2020) (2)
Human immunodeficiency and hepatitis C virus coinfection influenced by interferon-gamma. (2000) (2)
Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs (2016) (2)
The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the Swiss Mother and Child HIV Cohort Study. (2019) (2)
Costs versus earnings in colon surgery and coronary artery bypass grafting under a prospective payment system: Sufficient financial incentives to reduce surgical site infections? (2018) (2)
Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR (2022) (2)
Aging does not impact drug-drug interaction magnitudes with antiretrovirals: a Swiss HIV Cohort Study. (2020) (2)
Mycobacterium kansasii Abscess of the Chest Wall After Drainage of Bacterial Empyema (2000) (2)
High-resolution influenza mapping of a city reveals socioeconomic determinants of transmission within and between urban quarters (2020) (2)
Mycobacterium-avium-Pneumonie bei HIV-negativem Patienten (2007) (2)
Morbidität und Mortalität der HIV-Infektion (2012) (2)
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link (2021) (2)
Knowing one's medical fate in advance : challenges for diagnosis and treatment, philosophy, ethics and religion (2012) (2)
[Prevention of catheter-related infections: minimizing secondary complications in geriatric patients]. (2013) (2)
Vermeidung katheterassoziierter Infektionen (2013) (2)
Disseminated tuberculosis in an HIV-infected child: rifampicin resistance detected by GeneXpert in a lymph node aspirate but not in cerebrospinal fluid (2015) (2)
Swiss HIV cohort study (SHCS): outcome and perspectives. (2001) (2)
Epidemiology of Schistosoma mansoni infection in Ituri Province, north-eastern Democratic Republic of the Congo (2020) (2)
Maraviroc (MVC) increases CD4+ and CD8+ cells: long-term data from the MVC clinical development program (2010) (2)
Influence of antiretroviral therapy on programmed death-1 (CD279) expression on T cells in lymph nodes of human immunodeficiency virus-infected individuals. (2009) (2)
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study. (2021) (2)
Corrigendum to: Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses (2020) (2)
The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study (2017) (2)
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV‐infected protease inhibitor‐naive patients (2001) (2)
Die virale Arthritis beim Erwachsenen (2018) (2)
Impfungen bei erwachsenen Flüchtlingen (2016) (2)
Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships (2017) (2)
[Mansonella perstans filariasis after stay in Cameroon. A 19-year-old patient born in Cameroon, in Switzerland for the last 10 years]. (2002) (2)
High acceptability of cognitive screening in HIV-infected patients: a pilot study (2012) (2)
[Mycobacterium avium pneumonia in an HIV negative patient]. (2007) (2)
[Sex differences in disease course: analysis of the Swiss HIV cohort study]. (1996) (2)
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART (2020) (2)
[Ready for antiretroviral therapy? Therapy decision making experiences of persons living with HIV]. (2005) (2)
Fokale mykobakterielle Lymphadenitis nach Beginn einer hochaktiven antiretroviralen Therapie (2008) (2)
Discontinuation of Enfuvirtide in Heavily Pretreated HIV-Infected Individuals (2009) (2)
Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area (2022) (2)
«3 by 5» – Ein WHO/UNAIDS-Plan – Können 3 Millionen Menschen bis Ende 2005 eine HIV-Therapie erhalten? (2005) (1)
Satellite Symposium at the 7th Congress of the European Academy of Dermatology and Venereology, Nice, October 9, 1998 (1999) (1)
[Clinical infectious diseases : interdisciplinary and unique]. (2013) (1)
[Clinical study of infectious diseases. An interdisciplinary challenge in medicine]. (2005) (1)
A Simple Visual Analog Scale is a Valuable Tool to Assess Self-ReportedAdherence in HIV-Infected Patients on Antiretroviral Treatment in aResource-Limited Setting (2017) (1)
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study. (2022) (1)
Su1052 Comparison of 24 and 48 Weeks of Treatment With Faldaprevir and Pegylated Interferon/Ribavirin in Patients With Detectable but Not Quantifiable HCV RNA At Week 4 (2014) (1)
[HIV in Sub-Saharan Africa: Where Are We Today?] (2019) (1)
[Neurological complications of HIV infection. Review: new diagnostic, therapeutic and prognostic aspects]. (2000) (1)
Low rates of active hepatitis B and C infections among adults and children living with HIV and taking antiretroviral therapy: A multicenter screening study in Lesotho (2020) (1)
Is CD95 or CD26 expression on T-cells a marker for HIV non- or slow-progressor status? (1998) (1)
149 Leishmaniasis in immunocompromised patients: Shift in risk factors from HIV to other immunosuppressive conditions. Retrospective analysis of 12 cases and review of the literature (2006) (1)
Revisiting Combination Antibiotic Therapy for Community-Acquired Invasive Streptococcus pneumoniae Pneumonia (2006) (1)
[Clinically significant drug interactions in HIV-infected patients]. (1998) (1)
Human immunodeficiency virus mutation and changes in CD4 T-cell levels during antiretroviral therapy (1998) (1)
recovery during antiretroviral therapy in the Swiss HIV Cohort Study (2013) (1)
Identifying and Characterizing Trans women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group. (2021) (1)
Prevalence, incidence and predictors of renal impairment in persons with HIV receiving protease-inhibitors in rural Tanzania (2021) (1)
P1133 COMPARISON OF 24 AND 48 WEEKS OF TREATMENT WITH FALDAPREVIR AND PEGYLATED INTERFERON/RIBAVIRIN IN PATIENTS WITH DETECTABLE BUT NOT QUANTIFIABLE HCV RNA AT WEEK 4 (2014) (1)
210 Low Post-Seroconversion CD4 Count and Rapid Decrease of CD4 Density Identify HIV+ Fast Progressors (2011) (1)
Quantifying and predicting ongoing Human Immunodeficiency Virus Type 1 (HIV-1) transmission dynamics in Switzerland using a distance-based clustering approach. (2022) (1)
Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxis (2021) (1)
Air temperature and incidence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. (2022) (1)
Sonnet for a Grecian (1991) (1)
Impact of HIV status on outcome of infectious complications in intravenous drug users. (2009) (1)
Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study (2017) (1)
Hyaluronic Acid as a Prognostic Marker of Hepatic Encephalopathy and Liver-related Death in HIV/Viral Hepatitis Coinfected Patients (2009) (1)
The doctor in his social aspect (2004) (1)
Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection. (2001) (1)
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19 (2020) (1)
[Initial patient assessment of infectious diseases and diagnostic steps with fever]. (2013) (1)
[Anti-retroviral therapy and antiepileptics. Case report and discussion]. (1998) (1)
Factors associated with the emergence of K 65 R in HIV-1 infected patients treated with combination antiretroviral therapy containing tenofovir (2009) (1)
The relationship of symptom experience and nonadherence in HIV (2007) (1)
An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa. (2016) (1)
[Therapy of severe fungal infections]. (2003) (1)
[Diagnostic procedures for patients with community acquired pneumonia]. (2007) (1)
Choice of initial therapy (2014) (1)
[53 year-old patient with fever and cough]. (2009) (1)
The significance of pre-existing minority Y181C mutations on virological failure of NNRTI-based, first-line antiretroviral therapy (2011) (1)
A comment on Marschall et Al. (2011) (1)
Improved services to enrollees into an HIV rural care and treatment center in Tanzania (2013) (1)
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin’s lymphoma (2021) (1)
Faldaprevir plus pegyliertes Interferon alpha-2a und Ribavirin (PR) bei Patienten mit HIV und Hepatitis C Genotyp (GT)-1 Koinfektion: End of Treatment Response (ETR) – Ergebnisse der Phase III Studie STARTVerso 4 (2014) (1)
Beneficial course of two cases of HIV-associated multicentric Castleman disease treated with HIV antiretroviral therapy. (2012) (1)
08 First case of spondylodiscitis caused by Actinobaculum schaalii, a rare pathogen causing urinary tract infection in the elderly (2006) (1)
A short tool to screen HIV-infected patients for mild neurocognitive disorders – a pilot study (2014) (1)
Homozygosity Is Associated with an Impaired CD 4 T Cell Recovery after Initiation of Antiretroviral Therapy (2008) (1)
[HIV post-exposure prophylaxis after sexual risk contact]. (1999) (1)
SARS-CoV-2 phylogeny during the early outbreak in the Basel area, Switzerland: import and spread dominated by a single B.1 lineage variant (C15324T) (2020) (1)
The role of HIV asymptomatic status when starting ART on adherence and treatment outcomes and implications for test and treat: the Swiss HIV Cohort Study. (2020) (1)
Evolving Therapy and Prognosis in HIV – How Knowing One’s Medical Fate in Advance Can Change Dramatically (2012) (1)
Offering ART Refill Through Community Health Workers Versus Clinic-Based Follow-Up After Home-Based Same-Day ART Initiation: The VIBRA Cluster-Randomised Clinical Trial (2021) (1)
Serious Fatal and Non-Fatal Non-AIDS D efining Illnesses (non-ADI) in Europe (2009) (1)
["HAART-attack" in young female HIV-patient]. (2006) (1)
„HAART-Attack“ bei junger HIV-Patientin (2006) (1)
Limitations in study on benefits of clindamycin. (2015) (1)
Lamivudine for chronic hepatitis B. (1998) (1)
A Preliminary Review of its Immunogenicity, Protective Efficacy and Tolerability in At-Risk Populations (1997) (1)
HIV transmission chains exhibit greater HLA-B homogeneity than randomly expected. (2019) (1)
Treatment of an atazanivir associated grade 4 hyperbilirubinaemia with efavirenz (2007) (1)
Observational cohort study of rilpivirine (RPV) utilization in Europe (2022) (1)
Antiretroviral Therapy Reduces Markers of Endothelial and Coagulation Activation in Patients Infected with Human Immunodeﬁciency Virus Type 1 for the Swiss HIV Cohort Study (2002) (1)
CALCIUMCARBONAT FUR DIE BEHANDLUNG DER HYPERPHOSPHATAMIE BEI CHRONISCHEN HAMODIALYSEPATIENTEN (1990) (1)
Oligoarthritis durch Tropheryma whipplei (2010) (1)
Die Haut, ein interdisziplinäres Organ (2009) (1)
Psychosoziale Aspekte bei der Behandlung der HIV-Infektion (2014) (1)
Lunge und Infektion (2007) (1)
Vermeidung katheterassoziierter Infektionen (2012) (1)
Haut- und Schleimhautinfektionen bei Immunsuppression (2009) (1)
53-jähriger Patient mit Fieber und Husten (2009) (1)
Viruses Escaping Immunological Surveillance (1993) (0)
A qualitative study on safety perception among healthcare workers of a tertiary academic care center during the SARS-CoV-2 pandemic (2022) (0)
Front & Back Matter (2013) (0)
Stigma-directed services (Stig2Health) to improve ‘linkage to care’ for people living with HIV in rural Tanzania: study protocol for a nested pre-post implementation study within the Kilombero and Ulanga Antiretroviral Cohort (2022) (0)
[Fever, coughing and dyspnea in a 38-year-old female kidney transplant recipient]. (2012) (0)
Prävention der Virushepatitis A bis E (2011) (0)
65 Partial normalization of the activated immune response in lymph nodes of HIV-infected individuals under ART (2006) (0)
Front & Back Matter (2012) (0)
Epidemiologie von Hautkrankheiten bei HIV-Infizierten: Die Basler Kohortenstudie (1998) (0)
combination antiretroviral therapy: the Swiss HIV Cohort Study (2016) (0)
[57-year-old patient with unclear cutaneous finding]. (2016) (0)
Are three antiseptic paints needed for safe preparation of the surgical field? A prospective cohort study with 239 patients (2020) (0)
[10 years' therapy of Hodgkin's disease in the Oncology Department of the Basel Canton Hospital: a retrospective study]. (1987) (0)
JC Virus-Speciﬁc Immune Responses in Human Immunodeﬁciency Virus Type 1 Patients with Progressive Multifocal Leukoencephalopathy (cid:1) HIV Cohort (2009) (0)
[Drug-drug interactions with HIV treatments]. (2011) (0)
Impact of health insurance status on surgical site infection incidence: A prospective cohort study (2019) (0)
[Status febrilis and unconsciousness]. (2005) (0)
71 Discontinuation of enfuvirtide after long-term administration in HIV-1-infected patients: the Swiss HIV cohort study (SHCS) (2006) (0)
Disappearance of an intracerebral arteriovenous malformation in an HIV-1-infected patient after initiation of HAART. Commentary (2003) (0)
[Prevention of catheter-related infections]. (2012) (0)
Assessing efﬁcacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study (2015) (0)
[Quality aspects in internal medicine--from anamnesis to meta-analysis]. (1998) (0)
KAPITEL C8 – HIV und AIDS (2008) (0)
Ebola vaccination (2016) (0)
[Vaccination: advances and evidence]. (2011) (0)
Correction: A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa (2015) (0)
Case Report Fatal disseminated fusariosis presenting initially as tonsillitis (2014) (0)
42-jähriger, adipöser Patient mit beatmungspflichtiger H1N1-Infektion (2010) (0)
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor containing regimen. (2023) (0)
Modelling HIV virulence evolution in the context of immune escape (2014) (0)
Changing HIV guidelines: how to communicate treatment start (2010) (0)
Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group. (2022) (0)
outcome Analysis Of Diffuse Large B-cell Lymphoma (dlbcl) In Hiv-infected And Immunocompetent (ic) Patients: The Swiss Hiv Cohort Study (shcs) : 218 (2015) (0)
Characterisation of hepatitis C virus evolution in HIV/HCV coinfected individuals using deep sequencing technology: Relevance for new antiviral drugs and disease outcome (2010) (0)
Persistent High Burden and Mortality Associated With Advanced HIV Disease in Rural Tanzania Despite Uptake of World Health Organization “Test and Treat” Guidelines (2022) (0)
Author's response to reviews Title: Improved Sensitivity of an Interferon-Gamma Release Assay (T-SPOT.TB) in Combination with Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis in the Presence of HIV Infection Authors: (2011) (0)
Erratum to “Gastroenteritis outbreak with norovirus in a Swiss university hospital with a newly identified virus strain [Journal of Hospital Infection 2003;55:131–136]” (2004) (0)
Decreasing incidence and determinants of Bacterial Pneumonia in people with HIV: The Swiss HIV Cohort Study (2021) (0)
Decreasing Incidence and Determinants of Bacterial Pneumonia in HIV-Infected Individuals: The Swiss HIV Cohort Study (2021) (0)
[Check-up-examinations in internal medicine]. (2006) (0)
Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV (2022) (0)
' s response to reviews Title : Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Stud (2015) (0)
Impact of Latent Tuberculosis Infection on the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study. (2022) (0)
[Weight loss and chronic diarrhea in a 54-year-old man with HIV infection]. (2015) (0)
[When to start antiretroviral therapy]. (2014) (0)
Prescribing in COVID‐19 patients: Should we take into account inflammation? (2020) (0)
[Advances in management of HIV infections]. (2012) (0)
52 Infectious complications in patients treated for hematological malignancies (2006) (0)
interferon . virus to alpha / beta interferon and to gamma Resistance of lymphocytic choriomeningitis (0)
[Pneumothorax as a complication of Pneumocystis carinii pneumonia]. (2008) (0)
Vermeidung katheterassoziierter Infektionen (2012) (0)
Dissecting HIV Virulence : Heritability of Setpoint Viral Load , CD 4 + T-Cell Decline , and Per-Parasite Pathogenicity BERTELS (2018) (0)
[Challenges in HIV long-term care]. (2003) (0)
[Parasitic diseases]. (2006) (0)
Relationships between Symptom Experience, Mental Health, Social Support, Symptom manageability, adherence, quality of life, and HIV disease progression (2007) (0)
Symptom Experience in Persons living with HIV (PLWH): Is it the same for participants with and without Primary Support Persons (PSP)? (2007) (0)
Safety and tolerance of lymph node biopsies from chronic HIV-1 volunteers in rural Tanzania (2019) (0)
Ultrasononography in Managing Extrapulmonary Tuberculosis: A Randomized, Controlled, Parallel, Superiority, Open-Label Trial (2022) (0)
Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study (2022) (0)
Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections (2021) (0)
A systematic outbreak investigation of SARS-CoV-2 transmission clusters in a tertiary academic care center (2023) (0)
[Calcium carbonate for the treatment of hyperphosphatemia in chronic hemodialysis patients]. (1990) (0)
Abstracts of the 12th European AIDS Conference/EACS, 11-14 November 2009, Cologne, Germany. (2009) (0)
Patients with severe schistosomiasis mansoni in Ituri Province, Democratic Republic of the Congo (2021) (0)
[Generalized lymphadenopathy in a 43-year-old patient]. (2001) (0)
Fatal Acute Varicella-Zoster Virus Hemorrhagic Meningomyelitis with Necrotizing Vasculitis in an HIV-Infected Patient (2009) (0)
Kommentar zum STROBE-Statement (2008) (0)
Postoperative Wundinfektionen (2009) (0)
Prevalence and outcomes of pregnancies in women living with HIV over a 20-year period: The EuroSIDA study, 1996 to 2015. (2021) (0)
PS 2 – Hepatitis Co-infection PS 2 / 1 Efficacy of tenofovir plus emtricitabine compared to emtricitabine-based HAART in HIV / HBV-coinfected antiretroviral naı̈ve individuals in Thailand : a randomized controlled trial (2009) (0)
NOTFALLSITUATIONEN BEI HIV-INFEKTION (1998) (0)
Infektiologie: Antiretrovirale Therapie bei HIV: eine Möglichkeit der Prävention? (2011) (0)
[Hospitalizations in a cohort of 175 severely drug-addicted patients of a medically managed opiate withdrawal project]. (2001) (0)
Do we need national guidelines on human immunodeficiency virus treatment? (2012) (0)
A qualitative study on the perception of infection prevention and control measures among healthcare workers without patient contact during the SARS-CoV-2 pandemic (2023) (0)
2135. Costs vs. Earnings in Colon Surgery and Coronary Artery Bypass Grafting Under a Prospective Payment System: Sufficient Financial Incentives to Reduce Surgical Site Infections? (2018) (0)
Hepatitis C Virus (HCV) Coinfection Does Not Influence the CD 4 Cell Recovery in HIV-1 Infected Patients with Maximum Virologic Suppression within the EuroSIDA Cohort (2008) (0)
The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study (0)
The Chronic Diseases Clinic of Ifakara (CDCI)—Establishing a Model Clinic for Chronic Care Delivery in Rural Sub-Saharan Africa (2022) (0)
Air Temperature and Incidence of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae – An Observational Time-Series Regression Study (2021) (0)
Additional file 1: Appendix A. of Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study (2015) (0)
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine. (1997) (0)
[Prevention of catheter-related infections]. (2012) (0)
Identification of HCV minority species in HIV/HCV coinfected individuals using deep sequencing technology: relevance for new anti-HCV drugs and host immune responses to HCV. (2010) (0)
P0575 : Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV-coinfected patients: Zambia and Switzerland compared (2015) (0)
[Commentary on the STROBE statement. A checklist for observational studies improves transparency]. (2008) (0)
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals (2022) (0)
tuberculosis in participants in the Swiss HIV Cohort Study 2 (2014) (0)
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study (2022) (0)
Longer-Term Therapy for Symptoms Attributed to Lyme Disease. (2016) (0)
Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV (2022) (0)
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE (2020) (0)
[The value of clinical infectology]. (2005) (0)
Evidence based medicine (2008) (0)
[Vaccinations in adults]. (2001) (0)
[Endocarditis prevention following rheumatic fever?]. (1989) (0)
Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation (2023) (0)
Infektprävention im Fokus (2009) (0)
Mediastinal Hodgkin's disease--a retrospective analysis. (1988) (0)
Trastuzumab resistance: Bringing tailored therapy to the clinic (2008) (0)
Fatal disseminated fusariosis presenting initially as tonsillitis (2014) (0)
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses (2018) (0)
Reply to Parienti (2009) (0)
Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics (2022) (0)
Safety and tolerance of lymph node biopsies from chronic HIV-1 volunteers in rural Tanzania (2019) (0)
Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment. (2020) (0)
Comparative analysis of genomic features of human HIV-1 infection and primate models of SIV infection (2011) (0)
Cohort-derived machine learning models for individual prediction of chronic kidney disease in people living with HIV: a prospective multicentre cohort study (0)
HCV genotypes: Correlation with risk factors and response to interferon in Greek patients (1995) (0)
[Asymptomatic facial infiltrated papules in an HIV-positive male]. (2011) (0)
International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
[Antiretroviral therapy]. (2014) (0)
Klinische Infektiologie (2005) (0)
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin’s lymphoma (2021) (0)
Hepatitis delta virus (HDV) RNA in serum of patients with chronic delta hepatitis (1993) (0)
Welche Diagnose stellen Sie? (2016) (0)
57-jähriger Patient mit unklarem Hautbefund (2016) (0)
Fieber, Husten und Dyspnoe bei einer nierentransplantierten 38-jährigen Patientin (2012) (0)
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin’s lymphoma (2021) (0)
Exposition gegenüber HIV, Hepatitis B und C in Praxis und Spital : Vorbeugung und Post-Expositionsprophylaxe (2008) (0)
Human immunodeficiency virus-specific T lymphocyte cell (2001) (0)
Hinweise für Autoren (1987) (0)
Remdesivir wann ist sein Einsatz gegen Covid-19 indiziert (2021) (0)
Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV (2022) (0)
[Emergencies in HIV infection]. (1998) (0)
Politische Hetztirade und Geschichtsverfälschung (2013) (0)
Parasitäre Erkrankungen (2006) (0)
Woher kommt das Fieber? (2015) (0)
HIV-INFECTION UND LUES : FALLBESCHREIBUNG UND LITERATURUBERSICHT (1991) (0)
HIV-Infektion – wann ist eine antiretrovirale Therapie indiziert? (2014) (0)
Unklare asymptomatische infiltrierte Papeln im Gesicht eines HIV-infizierten Mannes (2011) (0)
10 Jahre Therapie des M. Hodgkin an der Onkologischen Abteilung des Kantonsspitals Basel: Eine retrospektive Analyse (1987) (0)
Infectiologie: Traitement antirétroviral: outil de prévention de linfection à VIH? (2011) (0)
Infektiologie: Neue gramnegative resistente Bakterien (2010) (0)
Stigma-directed services (Stig2Health) to improve 'linkage to care' for people living with HIV in rural Tanzania: study protocol for a nested pre-post implementation study within the Kilombero and Ulanga Antiretroviral Cohort. (2022) (0)
Impfungen: Fortschritte und Evidenz (2011) (0)
Infektionen bei erwachsenen Flüchtlingen (2016) (0)
Status febrilis mit Bewusstlosigkeit (2005) (0)
Fortschritte im Management der HIV-Infektion (2012) (0)
[Travel in a smaller world]. (2004) (0)
Violette Schwellung im Mund (2011) (0)
[The Basel Medical University Polyclinic on the brink of the 21st century: retrospective and prospective view]. (2001) (0)
Haut- und Schleimhautinfektionen bei Immunsuppression (2009) (0)
Isolationsmaßnahmen bei Infektionen der Luftwege (2010) (0)
[Acute digitoxin poisoning]. (1989) (0)
Publisher's Note / Editor's Note (1991) (0)
KLINISCH SIGNIFIKANTE MEDIKAMENTOSE INTERAKTIONEN BEI HIV-INFIZIERTEN PATIENTEN (1998) (0)
Gewichtsverlust und chronische Diarrhö bei einem 54-jährigen Mann mit HIV-Infektion (2015) (0)
Wo HIV-Betreuung in Afrika wirkt (2008) (0)
Geschlechtsunterschiede im Krankheitsverlauf: Analyse der schweizerischen HIV-Kohortenstudie (1996) (0)
Diagnostik von Parasiteninfektionen Stellenwert der Serologie (2006) (0)
Assessing HIV-positive Persons’ Readiness to Start and Maintain ART (2013) (0)
Switch from a ritonavir to a cobicistat containing antiretroviral regimen and impact on tacrolimus levels in a kidney transplant recipient (2023) (0)
[Can HIV/AIDS be healed with new therapies?]. (1997) (0)
A systematic phylogenetic approach to study the interaction of HIV-1 with coinfections, non-communicable and opportunistic diseases (0)
[The 3' by 5' WHO/UNAIDS initiative--can 3 million people obtain HIV therapies by the end of 2005]. (2005) (0)
Limitations in Study on Bene fi ts of Clindamycin (2014) (0)
Infektiologische Erstbeurteilung und erste Abklärungsschritte bei Fieber (2013) (0)
POLYPHARMACY, DRUG-DRUG INTERACTIONS AND INAPPROPRIATE DRUGS: NEW CHALLENGES IN THE AGING POPULATION LIVING WITH HIV (2019) (0)
Ambiguity in population-based sequencing of HIV-1 as a marker for the age of HIV infection (2010) (0)
Su1055 Impact of Baseline Variables on Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Patients With HIV/HCV Genotype-1 Coinfection in a Phase III Trial (2014) (0)
O120 REDUCED INCIDENCE OF HEPATOCELLULAR CARCINOMA IN HIV/HBV-COINFECTED PATIENTS RECEIVING TENOFOVIR (2014) (0)
Is 95% self-reported adherence to antiretroviral therapy good enough? (2007) (0)
[42-year-old obese man with H1N1 influenza A infection necessitating mechanical ventilation]. (2010) (0)
Decentralization of viral load testing to improve HIV care and treatment cascade in rural Tanzania: observational study from the Kilombero and Ulanga Antiretroviral Cohort (2023) (0)
63 Epstein-Barr Virus-selective immuno-deficiency in HIV-infected individuals developing primary central nervous system lymphoma (2006) (0)
Evidence of Viral Adaptation to HLA Class I-Restricted Immune Pressure in Chronic Hepatitis C Virus Infection (2007) (0)
P1157 IMPACT OF BASELINE VARIABLES ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN PATIENTS WITH HIV/HCV GENOTYPE-1 COINFECTION IN A PHASE III TRIAL (2014) (0)
Reisen in einer kleineren Welt (2004) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
Correction: Probiotics for Ulcerative Colitis (2010) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
Aids in Basel - Vom Sterben an Aids zum Leben mit HIV (2018) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Manuel Battegay?

Manuel Battegay is affiliated with the following schools:

University of Zurich
University of Western Australia
University of Lausanne
University of Basel
University of Geneva